Aurobindo Pharma Limited — Updates, 13-03-2026: General Updates
13-03-2026 | 12:54 pm
13-03-2026 | 12:54 pm
Aurobindo Pharma faces a tax order upholding GST demand and penalty of ₹77.61 Cr each. The company has already paid ₹23.72 Cr and reversed ₹8.78 Cr ITC. No material financial impact is expected; the company plans to appeal.
No comments yet. Be the first to comment!
